Bridging with Idelalisib appears safe in patients with chronic lymphocytic leukemia (CLL) prior to allogeneic hematopoietic stem cell transplantation (alloHCT): A Report from the EBMT Chronic Malignancies Working Party
BONE MARROW TRANSPLANTATION(2017)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要